Health & Fitness
Health and Fitness
Health and Fitness 
Thu, October 1, 2009
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - WOPRAI
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - WOPRAI
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - WOPRAI
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - WOPRAI
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - WOPRAI
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
[ Thu, Oct 01st 2009
] - Market Wire
Wed, September 30, 2009
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - WOPRAI
[ Wed, Sep 30th 2009
] - WOPRAI
[ Wed, Sep 30th 2009
] - WOPRAI
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - WOPRAI
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
[ Wed, Sep 30th 2009
] - Market Wire
Quest PharmaTech Acquires Late-Stage Immunotherapeutic Antibody Pipeline
- Combination with chemotherapy: A recent 40-patient randomized clinical trial (Journal of Immunotherapy, 2009, Volume 32, page 54- 65) established that front-line carboplatin-paclitaxel chemotherapy has immune adjuvant properties when administered concurrent to the anti-CA125 antibody, and immunity is enhanced relative to that which is achievable in an antibody treatment alone; - Combination with photodynamic therapy: In recent preclinical studies done at the BC Cancer Agency (Photochemistry and Photobiology, 2009, DOI:1111, European Patent No. 1,357,944), Quest showed that the therapeutic outcome of SL052 mediated photodynamic therapy can be improved by a combination with antibody mediated immunotherapy; and - Combination with radioimmuno therapy: The use of Oregovomab, radiolabeled with an appropriate therapeutic isotope, has the potential to provide the benefits of antibody mediated immune response as well as antigen-bearing tumor cell radiotoxicity. Such a concept has already been established in a preclinical setting (Applied Radiation and Isotopes, 1997, Volume 48, pages 899-906).
"Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release."
Similar Health and Fitness Articles
[ Thu, Sep 03rd 2009
] - Market Wire
[ Mon, Aug 24th 2009
] - Market Wire
[ Tue, Jun 23rd 2009
] - Market Wire
[ Tue, Jun 16th 2009
] - Market Wire
[ Sat, May 30th 2009
] - Market Wire
[ Wed, May 20th 2009
] - Market Wire
[ Thu, Feb 26th 2009
] - Market Wire
[ Mon, Dec 08th 2008
] - Market Wire
[ Wed, Nov 19th 2008
] - Market Wire